Monthly Archives: January 2020

Hitado GmbH becomes Nexus IB10 distributor for sphingotec in Germany and Switzerland

Norderstedt and Hennigsdorf, Germany, January 14, 2020 – Hitado GmbH (Hitado), a Sysmex point-of-care subsidiary, and SphingoTec GmbH (sphingotec) have signed an exclusive distribution agreement for the commercialisation of the Nexus IB10 diagnostic platform by Hitado in Germany. Further, Sysmex Suisse AG will commercialise the platform in Switzerland. The Nexus IB10 platform is a fully…
Read more

sphingotec launches IVD test for kidney function biomarker penKid® on Nexus IB10 POCT platform

sphingotec launches a CE-marked point-of-care IVD assay for Proenkephalin (penKid®), the company‘s proprietary biomarker for real-time assessment of kidney function in critical care settings IB10 sphingotest® penKid® runs on sphingotec's automated Nexus IB10 point-of-care platform and quantitatively measures levels of penKid® directly in whole blood samples penKid® is a functional kidney biomarker reflecting the actual…
Read more

sphingotec transforms into end-to-end diagnostic solutions provider and exclusively represents Nexus Dx IB10 immunoassay portfolio

• Following the acquisition and integration of former Samsung subsidiary Nexus Dx Inc., sphingotec becomes a fully integrated diagnostic solutions provider • Nexus Dx IB10 POC immunoassay platform (formerly branded as Samsung LabgeoIB10) including its entire test portfolio for critical care environments will be marketed through sphingotec’s distributor network • After introducing the assay for…
Read more